We are live on
!
Find out more
TGI
TRV GP II Portfolio holdings
AUM
$1.34M
1-Year Est. Return
67.55%
This Fund
S&P 500
This Quarter
Est. Return
-21.47%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
–
AUM
$9.8M
AUM Growth
-$14.4M
(-59%)
Cap. Flow
-$9.62M
Cap. Flow
% of AUM
-98.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$9.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
IVAV
VM
CL
GAM
MC
NC
HCIG
NP
TRV GP II's Q1 2022 Portfolio in Review
As of Q1 2022, TRV GP II held 2 positions worth $9.8M, down 59% from $24.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP II withdrew a net $9.62M in Q1 2022, reducing 1 holding. Its largest reduction was Jounce Therapeutics, Inc. Common Stock, cutting an estimated $9.62M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP II's biggest Q1 2022 reduction was Jounce Therapeutics, Inc. Common Stock, cutting an estimated $9.62M.
- TRV GP II's ten largest holdings make up 100% of its $9.8M portfolio in Q1 2022.
- TRV GP II opened 0 new positions and closed 0 in Q1 2022.
- TRV GP II's portfolio value fell 59% quarter-over-quarter to $9.8M.
Based on TRV GP II's 13F filing for Q1 2022, filed 10 May 2022.